Geyer CE Jr, Bandos H, Rastogi P, Jacobs SA, et al. Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). Breast Cancer Res Treat 2022 Mar 1. pii: 10.1007/s10549-021-06417.
PMID: 35230585